1. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens;Serruto;Vaccine,2012
2. Immunisation of the immunocompromised child;Pinto;J. Infect.,2016
3. European Medicines Agency. Bexsero Assessment Report. 〈http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002333/human_med_001614.jsp&〉. (Accessed 17 May 2023).
4. U.S. Food and Drug Administration. Bexsero Product Information. 〈https://www.fda.gov/vaccines-blood-biologics/vaccines/bexsero〉. (Accessed 17 May 2023).
5. ACQUITY UPLC H-Class and H-Class Bio Amino Acid Analysis System Guide, Revision B, Waters Corporation, 2012 Manchester, UK. 〈https://www.waters.com/webassets/cms/support/docs/acq_uplc_h-class_aaa_sysgd_rev_b.pdf〉 (Accessed 17 May 2023).